PL

Plumbline Life Sciences, Inc.

Develops DNA vaccines and therapeutics for companion animals and livestock.

222670 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 서초구 반포대로 222성의교정 성의회관 1315호, 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Plumbline Life Sciences, Inc. is an animal biopharmaceutical company that develops a new class of nucleic acid-based DNA medicines. Utilizing its proprietary DNA platform technology, the company creates vaccines and therapeutics for the global animal health market, targeting both companion animals and livestock. Its development pipeline includes 'Renewdog', a first-in-class DNA therapeutic for canines, and other products for applications such as oncology and infectious disease prevention. The company's technology is designed to produce potent, safe, and room-temperature stable treatments with a simplified manufacturing process.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Plumbline Life Sciences, Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Plumbline Life Sciences, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Plumbline Life Sciences, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Tego Science, Inc. Logo
Develops cell therapies for skin regeneration, 3D models for testing, and provides CDMO services.
South Korea 191420
Teva Pharmaceutical Industries Ltd. Logo
A leader in affordable generic drugs and innovative specialty treatments for complex diseases.
Israel TEVA
THERAGEN ETEX CO.,LTD. Logo
A biotech firm offering gene analysis and developing personalized cancer drugs.
South Korea 066700
TheraVet SA Logo Belgium ALVET
Thor Medical ASA Logo
Sustainably produces alpha-emitters from thorium for cancer therapies, without nuclear reactors.
Norway NANOV
Tikun Olam Cannbit Pharmaceuticals Ltd. Logo
A vertically integrated pharma company developing research-backed, EU-GMP medical cannabis products.
Israel TKUN
TiumBio Co., Ltd. Logo
Clinical-stage biopharma developing therapies for rare diseases, gynecology, and hemophilia.
South Korea 321550
TMS Co., Ltd Logo
Develops small molecule drugs from natural compounds for the global pharmaceutical market.
Japan 4891
Together Pharma Ltd. Logo
Researches and produces medical cannabis products for domestic and European patients.
Israel TGTR
A pharmaceutical specialist in drugs for renal, skin, and allergic diseases.
Japan 4551

Talk to a Data Expert

Have a question? We'll get back to you promptly.